/
Unless otherwise noted or the context otherwise requires, all references in this section to Envoy Medical, we, us or our refer to Envoy Medical, Inc. following the Business Combination, other than certain historical information which refers to the business of Legacy Envoy prior to the consummation of the Business Combination. Overview We are a hearing health company focused on providing innovat…
The business is unprofitable at the operating level (-9240.66% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue grew 7.1%, steady but not accelerating. Margins contracted 682.4pp, which offsets some of the top-line progress.
ROIC dropped from -228.05% to -314.22%, capital efficiency is deteriorating. Negative free cash flow of -$18M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$234K
▲ +7.1% YoY
Net Income (TTM)
-$23M
▼ -14.2% YoY
Op. Margin
-9881.20%
▼ -682.4pp YoY
ROIC
-659.44%
▼ -86.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$21M
▲ +2.9% YoY
Op. Cash Flow (TTM)
-$21M
▼ -1.4% YoY
Net Debt
-$25M
Net Cash Position
Cash & Equiv.
$25M
3Y CAGR: +0.6%
Continue Research